Cargando…

Impaired neural pathway in gastric muscles of patients with diabetes

To explore the pathogenic mechanism of diabetic gastropathy, we investigated differences in response to electrical field stimulation (EFS) of gastric muscles from diabetic and non-diabetic (control) patients. Gastric specimens were obtained from 34 patients and 45 controls who underwent gastrectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Yang Won, Ko, Eun-Ju, Lee, Ji-Yeon, Rhee, Poong-Lyul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940896/
https://www.ncbi.nlm.nih.gov/pubmed/29739973
http://dx.doi.org/10.1038/s41598-018-24147-y
_version_ 1783321180793470976
author Min, Yang Won
Ko, Eun-Ju
Lee, Ji-Yeon
Rhee, Poong-Lyul
author_facet Min, Yang Won
Ko, Eun-Ju
Lee, Ji-Yeon
Rhee, Poong-Lyul
author_sort Min, Yang Won
collection PubMed
description To explore the pathogenic mechanism of diabetic gastropathy, we investigated differences in response to electrical field stimulation (EFS) of gastric muscles from diabetic and non-diabetic (control) patients. Gastric specimens were obtained from 34 patients and 45 controls who underwent gastrectomy for early gastric cancer. Using organ bath techniques, we examined peak and nadir values of contraction under EFS. To examine responses to purinergic and nitrergic inhibition without cholinergic innervation, atropine, MRS2500, and N-nitro-L-arginine (L-NNA) were added sequentially to the organ bath. Tetrodotoxin (TTX) was used to confirm that the responses to EFS were mediated via neural stimulation. In the absence of pharmacological agents, peak contraction amplitude was greater in non-diabetic controls compared to diabetics only in the distal longitudinal gastric muscles. However, the nadir was greater in controls than in patients in both proximal and distal gastric circular muscles. Addition of MRS2500 could not decrease the nadir in both controls and patients, both in the proximal and distal stomach. However, L-NNA completely reversed the relaxation. TTX had no further effect on nadir. In conclusion, impaired inhibitory nitrergic neural pathway in both proximal and distal stomach and impaired excitatory cholinergic neural pathway in the distal stomach may contribute to the pathogenic mechanism underlying diabetic gastropathy.
format Online
Article
Text
id pubmed-5940896
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59408962018-05-14 Impaired neural pathway in gastric muscles of patients with diabetes Min, Yang Won Ko, Eun-Ju Lee, Ji-Yeon Rhee, Poong-Lyul Sci Rep Article To explore the pathogenic mechanism of diabetic gastropathy, we investigated differences in response to electrical field stimulation (EFS) of gastric muscles from diabetic and non-diabetic (control) patients. Gastric specimens were obtained from 34 patients and 45 controls who underwent gastrectomy for early gastric cancer. Using organ bath techniques, we examined peak and nadir values of contraction under EFS. To examine responses to purinergic and nitrergic inhibition without cholinergic innervation, atropine, MRS2500, and N-nitro-L-arginine (L-NNA) were added sequentially to the organ bath. Tetrodotoxin (TTX) was used to confirm that the responses to EFS were mediated via neural stimulation. In the absence of pharmacological agents, peak contraction amplitude was greater in non-diabetic controls compared to diabetics only in the distal longitudinal gastric muscles. However, the nadir was greater in controls than in patients in both proximal and distal gastric circular muscles. Addition of MRS2500 could not decrease the nadir in both controls and patients, both in the proximal and distal stomach. However, L-NNA completely reversed the relaxation. TTX had no further effect on nadir. In conclusion, impaired inhibitory nitrergic neural pathway in both proximal and distal stomach and impaired excitatory cholinergic neural pathway in the distal stomach may contribute to the pathogenic mechanism underlying diabetic gastropathy. Nature Publishing Group UK 2018-05-08 /pmc/articles/PMC5940896/ /pubmed/29739973 http://dx.doi.org/10.1038/s41598-018-24147-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Min, Yang Won
Ko, Eun-Ju
Lee, Ji-Yeon
Rhee, Poong-Lyul
Impaired neural pathway in gastric muscles of patients with diabetes
title Impaired neural pathway in gastric muscles of patients with diabetes
title_full Impaired neural pathway in gastric muscles of patients with diabetes
title_fullStr Impaired neural pathway in gastric muscles of patients with diabetes
title_full_unstemmed Impaired neural pathway in gastric muscles of patients with diabetes
title_short Impaired neural pathway in gastric muscles of patients with diabetes
title_sort impaired neural pathway in gastric muscles of patients with diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940896/
https://www.ncbi.nlm.nih.gov/pubmed/29739973
http://dx.doi.org/10.1038/s41598-018-24147-y
work_keys_str_mv AT minyangwon impairedneuralpathwayingastricmusclesofpatientswithdiabetes
AT koeunju impairedneuralpathwayingastricmusclesofpatientswithdiabetes
AT leejiyeon impairedneuralpathwayingastricmusclesofpatientswithdiabetes
AT rheepoonglyul impairedneuralpathwayingastricmusclesofpatientswithdiabetes